APO-TRANEXAMIC ACID tranexamic acid 500 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-tranexamic acid tranexamic acid 500 mg tablet blister pack

southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; purified talc; colloidal anhydrous silica; povidone; vanillin; macrogol 8000; magnesium stearate; titanium dioxide; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

APO-TRANEXAMIC ACID tranexamic acid 500 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-tranexamic acid tranexamic acid 500 mg tablet bottle

southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; purified talc; croscarmellose sodium; vanillin; povidone; macrogol 8000; titanium dioxide; magnesium stearate; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

XARELTO 2.5 MG Israel - English - Ministry of Health

xarelto 2.5 mg

bayer israel ltd - rivaroxaban - film coated tablets - rivaroxaban 2.5 mg - rivaroxaban - xarelto, co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.

Lixiana 15 mg Film-Coated Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

lixiana 15 mg film-coated tablets

a. menarini singapore pte. ltd. - edoxaban tosilate -

Lixiana 30 mg Film-Coated Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

lixiana 30 mg film-coated tablets

a. menarini singapore pte. ltd. - edoxaban tosilate -

Lixiana 60 mg Film-Coated Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

lixiana 60 mg film-coated tablets

a. menarini singapore pte. ltd. - edoxaban tosilate -

Xarelto tablets film-coated Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

xarelto tablets film-coated

bayer ag - rivaroxaban - tablets film-coated - 2,5mg

RIROXATOR 20MG FILM COATED TABLETS Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

riroxator 20mg film coated tablets

laboratories torrent (malaysia) sdn. bhd. - rivaroxaban -

RIROXATOR 15MG FILM COATED TABLETS Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

riroxator 15mg film coated tablets

laboratories torrent (malaysia) sdn. bhd. - rivaroxaban -

Ciprofloxacin Sandoz Film Coated Tablet 500mg Singapore - English - HSA (Health Sciences Authority)

ciprofloxacin sandoz film coated tablet 500mg

novartis (singapore) pte ltd - ciprofloxacin hcl monohydrate 594.6mg eqv ciprofloxacin - tablet, film coated - 500 mg - ciprofloxacin hcl monohydrate 594.6mg eqv ciprofloxacin 500 mg